SCHEMBL891416

SCHEMBL891416

O=C(C(F)F)C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL434753 0.95
SCHEMBL29120955 0.95
SCHEMBL71391 0.76
SCHEMBL7942078 0.76
SCHEMBL800702 0.76
SCHEMBL25362966 0.76
SCHEMBL18107112 0.76
SCHEMBL1059263 0.73 LMNA (0.32)
SCHEMBL9008685 0.73
SCHEMBL11599054 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025098503-A1 CEREBLON E3 UBIQUITIN LIGASE INHIBITOR 甘李药业股份有限公司 2025-05-15 WO claimed
WO-2024240268-A1 CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION 甘李药业股份有限公司 2024-11-28 WO claimed
WO-2024156294-A1 ESTROGEN RECEPTOR PROTEOLYSIS TARGETING CHIMERA COMPOUND AND USE THEREOF 甘李药业股份有限公司 2024-08-02 WO claimed
CN-118139875-A Pharmaceutical composition containing acylated insulin 甘李药业股份有限公司 2024-06-04 CN claimed
WO-2024043228-A1 METHOD FOR PRODUCING LITHIUM HYDROXIDE AQUEOUS SOLUTION 株式会社アサカ理研 2024-02-29 WO claimed
CN-110997698-B Immunomodulatory agents acting as PD-1 antagonists 百时美施贵宝公司 2023-12-26 CN claimed
CN-117157306-A Immunomodulators 百时美施贵宝公司 2023-12-01 CN claimed
CN-116685313-A Indanyl-containing carboxylic acid compounds for the treatment of neurodegenerative diseases 细胞基因公司 2023-09-01 CN claimed
WO-2023143589-A1 CEREBLON E3 UBIQUITIN LIGASE INHIBITOR 甘李药业股份有限公司 2023-08-03 WO claimed
CN-115611933-A Process for preparing arginase inhibitors and synthetic intermediates thereof 因赛特公司 2023-01-17 CN claimed
WO-2010039792-A1 SELECTIVE PROTON COUPLED FOLATE TRANSPORTER AND FOLATE RECEPTOR, AND GARFTASE INHIBITOR COMPOUNDS AND METHODS OF USING THE SAME DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2010-04-08 WO claimed
US-20100081676-A1 SELECTIVE PROTON COUPLED FOLATE TRANSPORTER AND FOLATE RECEPTOR, AND GARFTASE INHIBITOR COMPOUNDS AND METHODS OF USING THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-04-01 US claimed
EP-2167951-A1 FFE MEDIA AND FFE METHODS COMPRISING VOLATILE SEPARATION MEDIA Becton, Dickinson and Company (US) 2010-03-31 EP claimed
WO-2008155420-A1 FFE MEDIA AND FFE METHODS COMPRISING VOLATILE SEPARATION MEDIA BECTON, DICKINSON & COMPANY (US) 2008-12-24 WO claimed
EP-1567677-A4 DETECTION OF PROTEASE ENZYMES MARLIGEN BIOSCIENCES INC (US) 2007-04-18 EP claimed
US-20060134774-A1 Detection of protease enzymes MARLIGEN BIOSCIENCES, INC. (US) 2006-06-22 US claimed
EP-1567677-A2 DETECTION OF PROTEASE ENZYMES MARLIGEN BIOSCIENCES, INC. (US) 2005-08-31 EP claimed
US-6774266-B2 Process for producing 1,1,1-trifluoroacetone CENTRAL GLASS COMPANY, LIMITED (JP) 2004-08-10 US claimed
WO-2004048935-A2 DETECTION OF PROTEASE ENZYMES MARLIGEN BIOSCIENCES, INC. (US) 2004-06-10 WO claimed
US-20030114713-A1 Process for producing 1,1,1- trifluoroacetone CENTRAL GLASS COMPANY, LIMITED (JP) 2003-06-19 US claimed